Comparing breathing and quality of life after two lung cancer surgeries
Compares breathlessness and quality of life after segmentectomy versus lobectomy for early lung cancer.
Plain-language title generated from the registry record
Registry title: Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer
Key facts
- Where
- Madrid, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with stage I non-small cell lung cancer who are having segmentectomy or lobectomy by keyhole (VATS) or robot-assisted (RATS) surgery. They fill in questionnaires before surgery and up to 12 months after.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Clinical stage I non-small cell lung cancer (NSCLC)
- Earlier treatment
- Cannot have had treatment before surgery (neoadjuvant treatment) or chest surgery in the previous year
Main reasons for not taking part
- Chest (thoracic) surgery in the previous year
- Neoadjuvant treatment (treatment given before surgery)
- Not completing the questionnaires before surgery
Read by machine on 13 November 2026.
Where in Spain
- Hospital Universitario Ramón y CajalMadrid, SpainContact: Sara Fra, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- Trial code
- NCT07477158
- Record updated
- 19 March 2026
- Original description
The goal is to compare patient reported outcomes, such as dyspnea, physical functioning and quality of life, between minimally invasive segmentectomy and lobectomy for stage I NSCLC during the first year after surgery.Read full original descriptionShow less
Living After Lung Surgery: Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer
The goal is to compare patient reported outcomes, such as dyspnea, physical functioning and quality of life, between minimally invasive segmentectomy and lobectomy for stage I NSCLC during the first year after surgery.
The main questions it aims to answer are:
* Do patients with stage I NSCLC that undergo minimally invasive segmentectomy have less postoperative dyspnea than patients that undergo lobectomy? * Do patients with stage I NSCLC that undergo minimally invasive segmentectomy have more favorable postoperative health related quality of life (HRQoL) than patients that undergo lobectomy? * Do patients with stage I NSCLC that undergo VATS segmentectomy or lobectomy have more favorable postoperative health related quality of life (HRQoL) than patients that undergo RATS segmentectomy or lobectomy?
Participants already undergoing surgical intervention as part of their regular medical care for resectable lung cancer will answer quality of life questionnaires preoperatively, at 1, 3, 6, and 12 months after surgery.
Inclusion: Patients with clinical stage I NSCLC who undergo segmentectomy or lobectomy with VATS or RATS.
Exclusion: Thoracic surgery in the previous year; Failure to complete preoperative questionnaires; Neoadyuvant treatment.